Patents by Inventor Thomas Delale

Thomas Delale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11192932
    Abstract: The present technology generally relates to compounds, in particular peptides comprising the heparin-binding domain (HBD) of insulin-like growth factor binding protein-2 (IGFBP-2) for the modulation of metabolic disorders. The present technology also generally relates to uses of such compounds in methods for preventing and/or treating metabolic disorders and in compositions and formulations for such uses.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: December 7, 2021
    Assignee: Amolyt Pharma
    Inventors: Thomas Delale, Stephane Milano, Thierry Abribat, David Clemmons
  • Publication number: 20210196789
    Abstract: The present technology generally relates to compounds, in particular peptides comprising the heparin-binding domain (HBD) of insulin-like growth factor binding protein-2 (IGFBP-2) for the modulation of metabolic disorders. The present technology also generally relates to uses of such compounds in methods for preventing and/or treating metabolic disorders and in compositions and formulations for such uses.
    Type: Application
    Filed: May 23, 2019
    Publication date: July 1, 2021
    Inventors: Thomas DELALE, Stephane MILANO, Thierry ABRIBAT, David CLEMMONS
  • Patent number: 10947285
    Abstract: The present technology generally relates to peptides of IGFBP-2 that may be used to improve bone disorders. The present technology also generally relates to uses of such peptides in methods for preventing or treating bone disorders and to compositions for such uses.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: March 16, 2021
    Assignee: Amolyt Pharma
    Inventors: David Clemmons, Gang Xi, Thomas Delale, Michel Julien, Thierry Abribat
  • Publication number: 20190359676
    Abstract: The present technology generally relates to compounds, in particular peptides comprising the heparin-binding domain (HBD) of insulin-like growth factor binding protein-2 (IGFBP-2) for the modulation of metabolic disorders. The present technology also generally relates to uses of such compounds in methods for preventing and/or treating metabolic disorders and in compositions and formulations for such uses.
    Type: Application
    Filed: May 23, 2019
    Publication date: November 28, 2019
    Inventors: Thomas DELALE, Stephane MILANO, Thierry ABRIBAT, David CLEMMONS
  • Publication number: 20190352358
    Abstract: The present technology generally relates to peptides of IGFBP-2 that may be used to improve bone disorders. The present technology also generally relates to uses of such peptides in methods for preventing or treating bone disorders and to compositions for such uses.
    Type: Application
    Filed: February 5, 2018
    Publication date: November 21, 2019
    Inventors: David CLEMMONS, Gang XI, Thomas DELALE, Michel JULIEN, Thierry ABRIBAT
  • Publication number: 20180230191
    Abstract: The present technology generally relates to peptides of IGFBP-2 that may be used to improve bone disorders. The present technology also generally relates to uses of such peptides in methods for preventing or treating bone disorders and to compositions for such uses.
    Type: Application
    Filed: February 5, 2018
    Publication date: August 16, 2018
    Inventors: David Clemmons, Gang Xi, Thomas Delale, Michel Julien, Thierry Abribat